Instrument Inactif

Cours BioMimetic Therapeutics, Inc.

Actions

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

BioMimetic Therapeutics, Inc. : Initiates Enrollment in Augment? Chronic Tendinopathy Clinical Trial	03/01/13
BioMimetic Therapeutics, Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of BioMimetic Therapeutics, Inc.	20/11/12
BioMimetic Therapeutics, Inc. : BioMimetic Therapeutics Investor Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Sale to Wright Medical Group	20/11/12
BioMimetic Therapeutics, Inc. : Wright Medical Group, Inc. and BioMimetic Therapeutics, Inc. Enter into Agreement to Combine Businesses	19/11/12
BioMimetic Therapeutics, Inc. : Reports Third Quarter 2012 Financial Results	05/11/12

Secteur

	Varia. 1 janv.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+15,82%	121 Md
REGENERON PHARMACEUTICALS, INC.	+20,35%	113 Md
ARGENX SE	+17,47%	26,02 Md
BIONTECH SE	-25,31%	19,39 Md
GENMAB A/S	-19,51%	15,91 Md
BEIGENE, LTD.	-19,67%	15,09 Md
WUXI APPTEC CO., LTD.	-46,87%	15,06 Md
SAREPTA THERAPEUTICS, INC.	+62,55%	14,93 Md
NEUROCRINE BIOSCIENCES, INC.	+6,34%	13,85 Md